Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jafron’s hemoperfusion cartridges and adsorption columns are widely used in clinical practice globally. Their HA series disposable hemoperfusion cartridge has been adopted in over 8,000 hospitals across 90+ countries with more than 5 million annual clinical applications. Clinical studies—including RCTs—demonstrate efficacy in reducing cytokine levels and improving outcomes in severe conditions such as COVID‐19–related cytokine storm. The company’s products are included in treatment guidelines for COVID‐19 and other critical illnesses in multiple countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jafron Biomedical.